MD223Z - Metodă de revaccinare a copiilor împotriva hepatitei virale B - Google Patents

Metodă de revaccinare a copiilor împotriva hepatitei virale B Download PDF

Info

Publication number
MD223Z
MD223Z MDS20100040A MDS20100040A MD223Z MD 223 Z MD223 Z MD 223Z MD S20100040 A MDS20100040 A MD S20100040A MD S20100040 A MDS20100040 A MD S20100040A MD 223 Z MD223 Z MD 223Z
Authority
MD
Moldova
Prior art keywords
viral hepatitis
against viral
revaccination
hbs
level
Prior art date
Application number
MDS20100040A
Other languages
English (en)
Russian (ru)
Inventor
Анжела ВРЫНЧЯНУ-БЕНЕШ
Константин СПЫНУ
Петру ЯРОВОЙ
Виктор ПЫНТЯ
Original Assignee
Национальный Научно-Практический Центр Превентивной Медицины Министерства Здравоохранения Республики Молдова
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Национальный Научно-Практический Центр Превентивной Медицины Министерства Здравоохранения Республики Молдова filed Critical Национальный Научно-Практический Центр Превентивной Медицины Министерства Здравоохранения Республики Молдова
Priority to MDS20100040A priority Critical patent/MD223Z/ro
Publication of MD223Y publication Critical patent/MD223Y/ro
Publication of MD223Z publication Critical patent/MD223Z/ro

Links

Landscapes

  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Invenţia se referă la medicină, în special la boliile infecţioase şi poate fi utilizată pentru profilaxia hepatitei virale B.Conform invenţiei, metoda de revaccinare a copiilor împotriva hepatitei virale B constă în aceea că începând cu vârsta de un an, se determină anual nivelul de anticorpi anti-HBs şi, în cazul în care nivelul anti-HBs este de la 10 până la 150 mUI/ml, se administrează o doză booster de vaccin împotriva hepatitei virale B, iar în cazul în care nivelul anti-HBs este mai mic de 10 mUI/ml, se administrează un curs repetat din trei sau patru doze de vaccin împotriva hepatitei virale B.
MDS20100040A 2010-03-05 2010-03-05 Metodă de revaccinare a copiilor împotriva hepatitei virale B MD223Z (ro)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MDS20100040A MD223Z (ro) 2010-03-05 2010-03-05 Metodă de revaccinare a copiilor împotriva hepatitei virale B

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MDS20100040A MD223Z (ro) 2010-03-05 2010-03-05 Metodă de revaccinare a copiilor împotriva hepatitei virale B

Publications (2)

Publication Number Publication Date
MD223Y MD223Y (ro) 2010-06-30
MD223Z true MD223Z (ro) 2011-02-28

Family

ID=45815075

Family Applications (1)

Application Number Title Priority Date Filing Date
MDS20100040A MD223Z (ro) 2010-03-05 2010-03-05 Metodă de revaccinare a copiilor împotriva hepatitei virale B

Country Status (1)

Country Link
MD (1) MD223Z (ro)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD975Z (ro) * 2015-01-28 2016-07-31 Национальный Центр Общественного Здоровья Министерства Здравоохранения Республики Молдова Metodă de determinare a markerilor hepatitei virale B în sângele donatorului

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD3121G2 (ro) * 2005-09-15 2007-03-31 Национальный Научно-Практический Центр Превентивной Медицины Министерства Здравоохранения Республики Молдова Metodă de profilaxie a hepatitei virale B
  • 2010

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD3121G2 (ro) * 2005-09-15 2007-03-31 Национальный Научно-Практический Центр Превентивной Медицины Министерства Здравоохранения Республики Молдова Metodă de profilaxie a hepatitei virale B

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
Engerix B. Instrucţiune de utilizare a vaccinului contra hepatitei virale B. Smith Kline Beecham Biologicals S.A., *
Rue de 1’ Institut 89, 1330 Rixensart, Belgium, 2002 *
WHO. Hepatitis B vaccine. Weekly epidemiological record, no. 28, 2004, p. 79, 253-264,<URL: http://www.who.int/wer/en/ > găsit 2010.04.26 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD975Z (ro) * 2015-01-28 2016-07-31 Национальный Центр Общественного Здоровья Министерства Здравоохранения Республики Молдова Metodă de determinare a markerilor hepatitei virale B în sângele donatorului

Also Published As

Publication number Publication date
MD223Y (ro) 2010-06-30

Similar Documents

Publication Publication Date Title
Huo et al. The effect of vaccines on backward bifurcation in a fractional order HIV model
MD20140058A2 (en) Compositions and methods for treating hepatitis C virus
BR112018009009A8 (pt) terapia combinada de um inibidor de formação de capsídeo hbv e um interferon
CY1117819T1 (el) Ανοσοποιηση μεγαλων θηλαστικων με χαμηλες δοσεις rna
UA117246C2 (uk) Похідні сульфамоїлпіроламіду та їх застосування як медикаментів для лікування гепатиту в
BR112019004560A2 (pt) tratamento combinado com agonista de tlr7 e um inibidor de formação de capsídeo de hbv
IN2015DN01087A (ro)
PH12014500911A1 (en) Vaccines and methods for creating a vaccine for inducing immunity to all dengue virus serotypes
PH12020500445A1 (en) Combination therapies of hepatitis b virus (hbv)-infected individuals using parapoxvirus ovis (ppvo) and at least one further antiviral drug
MY178496A (en) Antibody composition for prevention or treatment of mutant hepatitis b virus infection
EA201290556A1 (ru) Оральная лекарственная форма, включающая энтекавир
NZ714347A (en) Method of treating intracellular infection
MD223Z (ro) Metodă de revaccinare a copiilor împotriva hepatitei virale B
PH12017500617B1 (en) Dosage regimen for pegylated interferon
MY202118A (en) Pharmaceutical composition that includes the surface and nucleocapsid antigens of the hepatitis b virus
Yang et al. The distribution and clinical sense of spontaneous YMDD mutation in 1444 patients chronic infected by HBV
UA59663U (ru) Способ профилактики заболевания острыми респираторными вирусными инфекциями у детей младшего школьного возраста в период сезонного повышения заболеваемости респираторными инфекциями
RU2005139920A (ru) Способ специфической профилактики вирусного гепатита b у взрослых, больных острыми лейкозами
Santoli VFC Resolution Update: Hepatitis B Vaccine [2016-10]
UA103870C2 (uk) Спосіб виявлення терапевтичної толерантності нейромодулятора природного походження ксигерм-1 при корекції експериментального синдрому стереотипної поведінки
QIU et al. Factors related to clinical relapse in patients with chronic hepatitis B after withdrawal of nucleos (t) ide analogues
Kumar A new frontier in mindfulness-based therapies.
UA87210U (ru) Способ лечения инфекционного мононуклеоза с синдромом холестаза эпштейна-барр вирусной этиологии у детей
You et al. Monotherapy with Clevudine and Sequential Therapy with Clevudine and Pegylated Interferon in HBeAg Positive Chronic Hepatitis B Patients with High Viral Load
Kim et al. Anti-viral treatment in patients with immune tolerant-phase chronic hepatitis B may be cost-effective

Legal Events

Date Code Title Description
MK4Y Short term patent expired